Loading
Latest filing published 15 Aug 2018 for Acerus Pharmaceuticals Corporation, €3,943.
All filings by Kae-Won Yoon on record concern Acerus Pharmaceuticals Corporation. We count 6 filings; the first trade dates from 1 June 2017 and the latest from 15 August 2018.
No open-market sale appears; the market trades are 5 purchases worth €32k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2018 to date brings 5 purchases and no sales.
In size, the median ticket on the buying side is €4,572. None of the 5 purchases we analysed coincided with buying by another insider of the same company within 30 days.
Most recently, on 15 August 2018, the filings show an open-market purchase worth €3,943 in Acerus Pharmaceuticals Corporation. The median gap between a trade and its publication by SEDI is 3 days. This delay matters because a trade only becomes useful information once it is public. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations